Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Surgeon General
  • Cigna’s ACA Exit
  • Visa Program
  • Medicaid Work Requirements
  • Gavin Newsom

TRENDING TOPICS:

  • Surgeon General
  • Cigna's ACA Exit
  • Visa Program
  • Medicaid Work Requirements
  • Gavin Newsom

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Tuesday, Mar 2 2021

Full Issue

Cities Starting To Detect Multiple Covid Variants

Houston hit an undesirable jackpot by being the first city in the U.S. to report infections from all the major known coronavirus variants.

Houston Chronicle: Houston Is First City To Record All Major COVID Strains, New Study Finds

Houston is the nation’s first city to record every major variant of the novel coronavirus — many of which are more contagious than the original strain. “The numbers of the major variants we have identified in our large sequencing study are disquieting,” said Dr. James Musser, who leads the team of experts at Houston Methodist Hospital behind the new finding. “The genome data indicate that these important variants are now geographically widely distributed in the Houston metropolitan region.” (Downen and Garcia, 3/1)

Bloomberg: New York Covid-19 Variant Expands Reach In U.S. With 735 Cases

About 735 cases of a coronavirus variant that emerged in New York City in November have now been identified in the U.S., including 585 in the last two weeks, a federal health official said. The mutation has traveled extensively through the metropolitan New York region, and individual cases have also been found in 14 other states, including Texas, Wyoming and Maryland, according to Gregory Armstrong, director of the Centers for Disease Control and Prevention’s Advanced Molecular Detection Program. (Court, Wingrove and Fabian, 3/1)

Fox News: 'Keep An Eye' On New York Coronavirus Variant, Fauci Warns

Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, on Monday urged a close watch of a coronavirus variant recently detected in New York. "We certainly are taking the New York variant, the 526 [referring to B.1.526] very seriously," Fauci said during a White House briefing, later adding, "We have to really keep an eye on that for its ability to evade both monoclonal antibodies and to a certain extent, the vaccine-induced antibodies, so it’s something we take very, very seriously." Fauci noted unknowns associated with the variant, like the degree and persistence of viral load in the nasopharynx, and whether variants emerge in immunocompromised individuals. His comments came after reporter Laurie Garrett questioned whether the variant first emerged in an HIV/AIDs patient. (Rivas, 3/1)

Also —

The New York Times: Virus Variant In Brazil Infected Many Who Had Already Recovered From Covid-19 

Three studies offer a sobering history of P.1’s meteoric rise in the Amazonian city of Manaus. It most likely arose there in November and then fueled a record-breaking spike of coronavirus cases. It came to dominate the city partly because of an increased contagiousness, the research found. But it also gained the ability to infect some people who had immunity from previous bouts of Covid-19. And laboratory experiments suggest that P.1 could weaken the protective effect of a Chinese vaccine now in use in Brazil. (Zimmer, 3/1)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Friday, May 1
  • Thursday, April 30
  • Wednesday, April 29
  • Tuesday, April 28
  • Monday, April 27
  • Friday, April 24
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF